Indolyl-urea derivatives of thienopyridines useful as antiangiogenic agents, and methods for their use

Indolyl-urea derivatives of thienopyridines useful as antiangiogenic agents, and methods for their use

This invention relates to novel thienopyridine and thienopyridine derivatives that are useful in the treatment of hyperproliferative diseases, such as cancers, in mammals. This invention also relates to a method of using such compounds in the treatment of hyperproliferative diseases in mammals, espe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Romines, III, William Henry, Kania, Robert Steven, Lou, Jihong, Cripps, Stephan, Zhou, Ru, He, Mingying
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Romines, III, William Henry
Kania, Robert Steven
Lou, Jihong
Cripps, Stephan
Zhou, Ru
He, Mingying
description This invention relates to novel thienopyridine and thienopyridine derivatives that are useful in the treatment of hyperproliferative diseases, such as cancers, in mammals. This invention also relates to a method of using such compounds in the treatment of hyperproliferative diseases in mammals, especially humans, and to pharmaceutical compositions containing such compounds. The invention relates to compounds represented by the formula I and to prodrugs thereof, pharmaceutically acceptable salts or solvates of said compounds or said prodrugs, wherein X, Rand Rare as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula I and to methods of treating hyperproliferative disorders in a mammal by administering the compounds of formula I.
format Patent
fullrecord <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_06833456</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>06833456</sourcerecordid><originalsourceid>FETCH-uspatents_grants_068334563</originalsourceid><addsrcrecordid>eNqNjEEKwjAQRbtxIeod5gAWhGhxL4ru3ctgJulAzJRMUujtTcADuHrw-O-vO_eIVsIS-pIIwVLiGTPPpCAO8sgUZVoSW45VFSVXAqACxswYPYunyG_Aiqz7qi18KI9iFZykekCcWrbtVg6D0u7HTQe36_Ny74tOmFv88gkbDsPZmONpMH9MvnjQQPw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Indolyl-urea derivatives of thienopyridines useful as antiangiogenic agents, and methods for their use</title><source>USPTO Issued Patents</source><creator>Romines, III, William Henry ; Kania, Robert Steven ; Lou, Jihong ; Cripps, Stephan ; Zhou, Ru ; He, Mingying</creator><creatorcontrib>Romines, III, William Henry ; Kania, Robert Steven ; Lou, Jihong ; Cripps, Stephan ; Zhou, Ru ; He, Mingying ; Agouron Pharmaceuticals, Inc</creatorcontrib><description>This invention relates to novel thienopyridine and thienopyridine derivatives that are useful in the treatment of hyperproliferative diseases, such as cancers, in mammals. This invention also relates to a method of using such compounds in the treatment of hyperproliferative diseases in mammals, especially humans, and to pharmaceutical compositions containing such compounds. The invention relates to compounds represented by the formula I and to prodrugs thereof, pharmaceutically acceptable salts or solvates of said compounds or said prodrugs, wherein X, Rand Rare as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula I and to methods of treating hyperproliferative disorders in a mammal by administering the compounds of formula I.</description><language>eng</language><creationdate>2004</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6833456$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,802,885,64038</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6833456$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Romines, III, William Henry</creatorcontrib><creatorcontrib>Kania, Robert Steven</creatorcontrib><creatorcontrib>Lou, Jihong</creatorcontrib><creatorcontrib>Cripps, Stephan</creatorcontrib><creatorcontrib>Zhou, Ru</creatorcontrib><creatorcontrib>He, Mingying</creatorcontrib><creatorcontrib>Agouron Pharmaceuticals, Inc</creatorcontrib><title>Indolyl-urea derivatives of thienopyridines useful as antiangiogenic agents, and methods for their use</title><description>This invention relates to novel thienopyridine and thienopyridine derivatives that are useful in the treatment of hyperproliferative diseases, such as cancers, in mammals. This invention also relates to a method of using such compounds in the treatment of hyperproliferative diseases in mammals, especially humans, and to pharmaceutical compositions containing such compounds. The invention relates to compounds represented by the formula I and to prodrugs thereof, pharmaceutically acceptable salts or solvates of said compounds or said prodrugs, wherein X, Rand Rare as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula I and to methods of treating hyperproliferative disorders in a mammal by administering the compounds of formula I.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2004</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNqNjEEKwjAQRbtxIeod5gAWhGhxL4ru3ctgJulAzJRMUujtTcADuHrw-O-vO_eIVsIS-pIIwVLiGTPPpCAO8sgUZVoSW45VFSVXAqACxswYPYunyG_Aiqz7qi18KI9iFZykekCcWrbtVg6D0u7HTQe36_Ny74tOmFv88gkbDsPZmONpMH9MvnjQQPw</recordid><startdate>20041221</startdate><enddate>20041221</enddate><creator>Romines, III, William Henry</creator><creator>Kania, Robert Steven</creator><creator>Lou, Jihong</creator><creator>Cripps, Stephan</creator><creator>Zhou, Ru</creator><creator>He, Mingying</creator><scope>EFH</scope></search><sort><creationdate>20041221</creationdate><title>Indolyl-urea derivatives of thienopyridines useful as antiangiogenic agents, and methods for their use</title><author>Romines, III, William Henry ; Kania, Robert Steven ; Lou, Jihong ; Cripps, Stephan ; Zhou, Ru ; He, Mingying</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_068334563</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2004</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Romines, III, William Henry</creatorcontrib><creatorcontrib>Kania, Robert Steven</creatorcontrib><creatorcontrib>Lou, Jihong</creatorcontrib><creatorcontrib>Cripps, Stephan</creatorcontrib><creatorcontrib>Zhou, Ru</creatorcontrib><creatorcontrib>He, Mingying</creatorcontrib><creatorcontrib>Agouron Pharmaceuticals, Inc</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Romines, III, William Henry</au><au>Kania, Robert Steven</au><au>Lou, Jihong</au><au>Cripps, Stephan</au><au>Zhou, Ru</au><au>He, Mingying</au><aucorp>Agouron Pharmaceuticals, Inc</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Indolyl-urea derivatives of thienopyridines useful as antiangiogenic agents, and methods for their use</title><date>2004-12-21</date><risdate>2004</risdate><abstract>This invention relates to novel thienopyridine and thienopyridine derivatives that are useful in the treatment of hyperproliferative diseases, such as cancers, in mammals. This invention also relates to a method of using such compounds in the treatment of hyperproliferative diseases in mammals, especially humans, and to pharmaceutical compositions containing such compounds. The invention relates to compounds represented by the formula I and to prodrugs thereof, pharmaceutically acceptable salts or solvates of said compounds or said prodrugs, wherein X, Rand Rare as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula I and to methods of treating hyperproliferative disorders in a mammal by administering the compounds of formula I.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_grants_06833456
source USPTO Issued Patents
title Indolyl-urea derivatives of thienopyridines useful as antiangiogenic agents, and methods for their use
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T11%3A40%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Romines,%20III,%20William%20Henry&rft.aucorp=Agouron%20Pharmaceuticals,%20Inc&rft.date=2004-12-21&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E06833456%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true